BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sokolov AV, Dostdar SA, Attwood MM, Krasilnikova AA, Ilina AA, Nabieva AS, Lisitsyna AA, Chubarev VN, Tarasov VV, Schiöth HB. Brain Cancer Drug Discovery: Clinical Trials, Drug Classes, Targets, and Combinatorial Therapies. Pharmacol Rev 2021;73:1-32. [PMID: 34663683 DOI: 10.1124/pharmrev.121.000317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bondarev AD, Attwood MM, Jonsson J, Chubarev VN, Tarasov VV, Liu W, Schiöth HB. Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1057083] [Reference Citation Analysis]
2 Niemi JVL, Sokolov AV, Schiöth HB. Neoantigen Vaccines; Clinical Trials, Classes, Indications, Adjuvants and Combinatorial Treatments. Cancers (Basel) 2022;14:5163. [PMID: 36291947 DOI: 10.3390/cancers14205163] [Reference Citation Analysis]
3 Pardridge WM. A Historical Review of Brain Drug Delivery. Pharmaceutics 2022;14:1283. [PMID: 35745855 DOI: 10.3390/pharmaceutics14061283] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
4 Barghout SH, Mann MK, Yu Y, Schimmer AD, Schapira M, Arrowsmith CH, Barsyte-lovejoy D. A combinatorial anticancer drug screen identifies off-target effects of epigenetic chemical probes.. [DOI: 10.1101/2022.04.14.488411] [Reference Citation Analysis]